New drug trial offers hope for Tough-to-Treat muscle diseases
NCT ID NCT07355257
Summary
This study is testing whether a drug called Telitacicept can help control inflammatory myopathy, a group of diseases where the immune system attacks muscles. Researchers will enroll 30 adults whose symptoms haven't improved enough with standard treatments like steroids or other immunosuppressants. The trial will measure how well the drug works and how safe it is for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY MYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.